Portfolio Holdings Detail for ISIN IE00BKVL7778
Stock Name / Fund iShares Edge MSCI World Minimum Volatility ESG UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares VI Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300VML6THE3JJOS76
ETF Ticker MVEW.DE(EUR) CXE
ETF Ticker MVEW.LS(GBP) CXE
ETF Ticker MVEW(USD) Euronext Amsterdam

Holdings detail for REGN

Stock Name	Regeneron Pharmaceuticals Inc
Ticker	REGN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US75886F1075
LEI	549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria: (RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages: Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL: Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors: Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN: In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC: Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.: Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.: D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares Edge MSCI World Minimum Volatility ESG UCITS ETF USD (Acc) REGN holdings

Date	Number of REGN Shares Held	Base Market Value of REGN Shares	Local Market Value of REGN Shares	Change in REGN Shares Held	Change in REGN Base Value	Current Price per REGN Share Held	Previous Price per REGN Share Held
2025-12-18 (Thursday)	1,090	USD 816,094	USD 816,094	0	USD -1,177	USD 748.71	USD 749.79
2025-12-17 (Wednesday)	1,090	USD 817,271	USD 817,271	0	USD 3,739	USD 749.79	USD 746.36
2025-12-16 (Tuesday)	1,090	USD 813,532	USD 813,532	0	USD -6,824	USD 746.36	USD 752.62
2025-12-15 (Monday)	1,090	USD 820,356	USD 820,356	0	USD 12,350	USD 752.62	USD 741.29
2025-12-12 (Friday)	1,090	USD 808,006	USD 808,006	0	USD -6,006	USD 741.29	USD 746.8
2025-12-11 (Thursday)	1,090	USD 814,012	USD 814,012	0	USD 22,443	USD 746.8	USD 726.21
2025-12-10 (Wednesday)	1,090	USD 791,569	USD 791,569	0	USD 36,657	USD 726.21	USD 692.58
2025-12-09 (Tuesday)	1,090	USD 754,912	USD 754,912	0	USD -11,641	USD 692.58	USD 703.26
2025-12-08 (Monday)	1,090	USD 766,553	USD 766,553	0	USD -16,459	USD 703.26	USD 718.36
2025-12-05 (Friday)	1,090	USD 783,012	USD 783,012	0	USD -4,840	USD 718.36	USD 722.8
2025-12-04 (Thursday)	1,090	USD 787,852	USD 787,852	0	USD -948	USD 722.8	USD 723.67
2025-12-03 (Wednesday)	1,090	USD 788,800	USD 788,800	0	USD -19,980	USD 723.67	USD 742
2025-12-02 (Tuesday)	1,090	USD 808,780	USD 808,780	-90	USD -76,350	USD 742	USD 750.11
2025-12-01 (Monday)	1,180	USD 885,130	USD 885,130	-15	USD -47,197	USD 750.11	USD 780.19

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00BKVL7778

Show aggregate share trades of REGN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 SELL -90 742.000* 652.08 Profit of 58,687 on sale
2025-12-01 SELL -15 779.840 748.210 751.373 USD -11,271 651.62 Loss of -1,496 on sale
2025-11-24 SELL -4,180 773.130 756.640 758.289 USD -3,169,648 648.57 Loss of -458,620 on sale
2025-11-11 SELL -69 676.330 651.410 653.902 USD -45,119 645.92 Loss of -551 on sale
2025-10-31 SELL -48 659.760 645.000 646.476 USD -31,031 645.90 Loss of -28 on sale
2025-10-30 SELL -560 664.000 645.000 646.900 USD -362,264 645.86 Loss of -584 on sale
2025-10-21 SELL -210 579.340 582.410 582.103 USD -122,242 647.53 Profit of 13,739 on sale
2025-10-17 SELL -70 578.050 579.040 578.941 USD -40,526 648.29 Profit of 4,854 on sale
2025-10-14 SELL -700 572.600 576.180 575.822 USD -403,075 649.54 Profit of 51,604 on sale
2025-10-02 SELL -700 600.000 605.410 604.869 USD -423,408 650.10 Profit of 31,658 on sale
2025-09-30 SELL -140 562.270 574.040 572.863 USD -80,201 650.87 Profit of 10,922 on sale
2025-09-26 SELL -420 563.900 564.610 564.539 USD -237,106 651.89 Profit of 36,686 on sale
2025-08-01 SELL -136 558.870 583.280 580.839 USD -78,994 656.69 Profit of 10,315 on sale
2025-07-31 SELL -109 545.460 558.130 556.863 USD -60,698 657.37 Profit of 10,955 on sale
2025-07-14 SELL -68 570.590 575.130 574.676 USD -39,078 661.36 Profit of 5,894 on sale
2025-07-07 BUY 119 538.110 547.590 546.642 USD 65,050 664.89
2025-06-30 BUY 145 525.000 526.080 525.972 USD 76,266 668.20
2025-06-27 SELL -130 521.000 531.210 530.189 USD -68,925 669.19 Profit of 18,070 on sale
2025-06-24 SELL -134 522.270 527.450 526.932 USD -70,609 672.25 Profit of 19,473 on sale
2025-06-13 SELL -134 529.240 529.550 529.519 USD -70,956 680.20 Profit of 20,191 on sale
2025-06-11 BUY 455 518.600 528.370 527.393 USD 239,964 682.55
2025-06-10 SELL -67 523.530 529.990 529.344 USD -35,466 683.73 Profit of 10,344 on sale
2025-05-21 SELL -65 604.620 617.520 616.230 USD -40,055 698.89 Profit of 5,373 on sale
2025-05-15 SELL -201 584.990 585.260 585.233 USD -117,632 702.32 Profit of 23,535 on sale
2025-05-12 BUY 67 575.630 577.990 577.754 USD 38,710 705.68
2025-05-09 BUY 782 527.780 552.840 550.334 USD 430,361 707.24
2025-05-07 BUY 201 560.930 568.130 567.410 USD 114,049 709.97
2025-04-23 BUY 189 587.850 603.770 602.178 USD 113,812 721.47
2025-04-22 BUY 126 585.490 587.100 586.939 USD 73,954 722.82
2025-04-14 SELL -134 571.060 574.720 574.354 USD -76,963 733.04 Profit of 21,264 on sale
2025-04-11 BUY 109 554.180 555.530 555.395 USD 60,538 734.94
2025-04-09 BUY 737 576.720 580.730 580.329 USD 427,702 738.71
2025-04-07 BUY 268 572.780 591.540 589.664 USD 158,030 742.58
2025-04-01 BUY 134 617.000 641.240 638.816 USD 85,601 747.31
2025-03-31 BUY 62 634.230 640.720 640.071 USD 39,684 748.62
2025-03-14 SELL -201 666.870 686.980 684.969 USD -137,679 762.26 Profit of 15,535 on sale
2025-03-10 BUY 67 744.830 748.290 747.944 USD 50,112 765.30
2025-03-07 BUY 268 707.510 729.750 727.526 USD 194,977 766.12
2025-03-04 BUY 201 675.490 697.460 695.263 USD 139,748 768.62
2025-02-28 BUY 52 698.740 708.580 707.596 USD 36,795 770.95
2025-02-21 SELL -66 700.330 704.080 703.705 USD -46,445 776.00 Profit of 4,771 on sale
2025-02-10 BUY 198 690.360 719.780 716.838 USD 141,934 792.94
2025-01-31 SELL -51 672.980 688.000 686.498 USD -35,011 805.37 Profit of 6,063 on sale
2025-01-02 SELL -726 715.190 726.810 725.648 USD -526,820 826.16 Profit of 72,971 on sale
2024-12-09 SELL -66 788.000 800.990 799.691 USD -52,780 828.48 Profit of 1,900 on sale
2024-11-29 SELL -65 750.220 754.510 754.081 USD -49,015 841.66 Profit of 5,693 on sale
2024-11-19 SELL -66 744.600 758.600 757.200 USD -49,975 886.01 Profit of 8,501 on sale
2024-11-18 SELL -132 762.000 762.700 762.630 USD -100,667 892.21 Profit of 17,104 on sale
2024-11-12 SELL -132 821.000 831.000 830.000 USD -109,560 895.96 Profit of 8,706 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	SELL	-90			742.000*		652.08 Profit of 58,687 on sale
2025-12-01	SELL	-15	779.840	748.210	751.373	USD -11,271	651.62 Loss of -1,496 on sale
2025-11-24	SELL	-4,180	773.130	756.640	758.289	USD -3,169,648	648.57 Loss of -458,620 on sale
2025-11-11	SELL	-69	676.330	651.410	653.902	USD -45,119	645.92 Loss of -551 on sale
2025-10-31	SELL	-48	659.760	645.000	646.476	USD -31,031	645.90 Loss of -28 on sale
2025-10-30	SELL	-560	664.000	645.000	646.900	USD -362,264	645.86 Loss of -584 on sale
2025-10-21	SELL	-210	579.340	582.410	582.103	USD -122,242	647.53 Profit of 13,739 on sale
2025-10-17	SELL	-70	578.050	579.040	578.941	USD -40,526	648.29 Profit of 4,854 on sale
2025-10-14	SELL	-700	572.600	576.180	575.822	USD -403,075	649.54 Profit of 51,604 on sale
2025-10-02	SELL	-700	600.000	605.410	604.869	USD -423,408	650.10 Profit of 31,658 on sale
2025-09-30	SELL	-140	562.270	574.040	572.863	USD -80,201	650.87 Profit of 10,922 on sale
2025-09-26	SELL	-420	563.900	564.610	564.539	USD -237,106	651.89 Profit of 36,686 on sale
2025-08-01	SELL	-136	558.870	583.280	580.839	USD -78,994	656.69 Profit of 10,315 on sale
2025-07-31	SELL	-109	545.460	558.130	556.863	USD -60,698	657.37 Profit of 10,955 on sale
2025-07-14	SELL	-68	570.590	575.130	574.676	USD -39,078	661.36 Profit of 5,894 on sale
2025-07-07	BUY	119	538.110	547.590	546.642	USD 65,050	664.89
2025-06-30	BUY	145	525.000	526.080	525.972	USD 76,266	668.20
2025-06-27	SELL	-130	521.000	531.210	530.189	USD -68,925	669.19 Profit of 18,070 on sale
2025-06-24	SELL	-134	522.270	527.450	526.932	USD -70,609	672.25 Profit of 19,473 on sale
2025-06-13	SELL	-134	529.240	529.550	529.519	USD -70,956	680.20 Profit of 20,191 on sale
2025-06-11	BUY	455	518.600	528.370	527.393	USD 239,964	682.55
2025-06-10	SELL	-67	523.530	529.990	529.344	USD -35,466	683.73 Profit of 10,344 on sale
2025-05-21	SELL	-65	604.620	617.520	616.230	USD -40,055	698.89 Profit of 5,373 on sale
2025-05-15	SELL	-201	584.990	585.260	585.233	USD -117,632	702.32 Profit of 23,535 on sale
2025-05-12	BUY	67	575.630	577.990	577.754	USD 38,710	705.68
2025-05-09	BUY	782	527.780	552.840	550.334	USD 430,361	707.24
2025-05-07	BUY	201	560.930	568.130	567.410	USD 114,049	709.97
2025-04-23	BUY	189	587.850	603.770	602.178	USD 113,812	721.47
2025-04-22	BUY	126	585.490	587.100	586.939	USD 73,954	722.82
2025-04-14	SELL	-134	571.060	574.720	574.354	USD -76,963	733.04 Profit of 21,264 on sale
2025-04-11	BUY	109	554.180	555.530	555.395	USD 60,538	734.94
2025-04-09	BUY	737	576.720	580.730	580.329	USD 427,702	738.71
2025-04-07	BUY	268	572.780	591.540	589.664	USD 158,030	742.58
2025-04-01	BUY	134	617.000	641.240	638.816	USD 85,601	747.31
2025-03-31	BUY	62	634.230	640.720	640.071	USD 39,684	748.62
2025-03-14	SELL	-201	666.870	686.980	684.969	USD -137,679	762.26 Profit of 15,535 on sale
2025-03-10	BUY	67	744.830	748.290	747.944	USD 50,112	765.30
2025-03-07	BUY	268	707.510	729.750	727.526	USD 194,977	766.12
2025-03-04	BUY	201	675.490	697.460	695.263	USD 139,748	768.62
2025-02-28	BUY	52	698.740	708.580	707.596	USD 36,795	770.95
2025-02-21	SELL	-66	700.330	704.080	703.705	USD -46,445	776.00 Profit of 4,771 on sale
2025-02-10	BUY	198	690.360	719.780	716.838	USD 141,934	792.94
2025-01-31	SELL	-51	672.980	688.000	686.498	USD -35,011	805.37 Profit of 6,063 on sale
2025-01-02	SELL	-726	715.190	726.810	725.648	USD -526,820	826.16 Profit of 72,971 on sale
2024-12-09	SELL	-66	788.000	800.990	799.691	USD -52,780	828.48 Profit of 1,900 on sale
2024-11-29	SELL	-65	750.220	754.510	754.081	USD -49,015	841.66 Profit of 5,693 on sale
2024-11-19	SELL	-66	744.600	758.600	757.200	USD -49,975	886.01 Profit of 8,501 on sale
2024-11-18	SELL	-132	762.000	762.700	762.630	USD -100,667	892.21 Profit of 17,104 on sale
2024-11-12	SELL	-132	821.000	831.000	830.000	USD -109,560	895.96 Profit of 8,706 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	208,659	1,635	312,812	66.7%
2025-09-18	236,485	3,679	387,519	61.0%
2025-09-17	229,191	716	370,895	61.8%
2025-09-16	173,632	584	271,020	64.1%
2025-09-15	204,491	251	334,496	61.1%
2025-09-12	117,504	33	222,760	52.7%
2025-09-11	125,478	3,137	286,516	43.8%
2025-09-10	195,068	481	339,885	57.4%
2025-09-09	129,168	994	274,520	47.1%
2025-09-08	250,895	396	527,062	47.6%
2025-09-05	170,149	290	289,566	58.8%
2025-09-04	188,227	2,103	360,619	52.2%
2025-09-03	185,679	344	438,111	42.4%
2025-09-02	191,954	138	476,288	40.3%
2025-08-29	133,226	685	236,726	56.3%
2025-08-28	116,560	2,177	256,675	45.4%
2025-08-27	113,719	465	243,836	46.6%
2025-08-26	210,376	450	400,199	52.6%
2025-08-25	149,130	68	363,377	41.0%
2025-08-22	211,822	3,244	701,770	30.2%
2025-08-21	257,492	3,416	446,439	57.7%
2025-08-20	327,738	572	559,133	58.6%
2025-08-19	118,472	2,191	324,311	36.5%
2025-08-18	146,282	388	277,909	52.6%
2025-08-15	209,923	3,375	441,752	47.5%
2025-08-14	157,569	3,623	429,327	36.7%
2025-08-13	111,342	233	362,786	30.7%
2025-08-12	117,647	171	310,775	37.9%
2025-08-11	129,513	2,676	284,757	45.5%
2025-08-08	128,559	1,038	431,841	29.8%
2025-08-07	166,648	1,560	352,877	47.2%
2025-08-06	176,311	624	397,089	44.4%
2025-08-05	154,257	115	353,744	43.6%
2025-08-04	200,758	1,913	409,897	49.0%
2025-08-01	349,775	3,745	728,720	48.0%
2025-07-31	222,350	476	549,344	40.5%
2025-07-30	106,839	1,689	231,761	46.1%
2025-07-29	149,359	276	292,667	51.0%
2025-07-28	103,687	1,380	245,287	42.3%
2025-07-25	103,783	556	259,069	40.1%
2025-07-24	156,974	2,397	291,677	53.8%
2025-07-23	168,734	1,708	355,372	47.5%
2025-07-22	116,324	617	304,880	38.2%
2025-07-21	98,482	900	250,107	39.4%
2025-07-18	183,174	1,051	391,909	46.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Edge MSCI World Minimum Volatility ESG UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares VI Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300VML6THE3JJOS76
ETF Ticker	MVEW.DE(EUR) CXE
ETF Ticker	MVEW.LS(GBP) CXE
ETF Ticker	MVEW(USD) Euronext Amsterdam